These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39193503)

  • 21. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burkholderia cepacia: medical, taxonomic and ecological issues.
    Govan JR; Hughes JE; Vandamme P
    J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection.
    Sabet M; Griffith DC
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712215
    [No Abstract]   [Full Text] [Related]  

  • 24.
    Hassan AA; Coutinho CP; Sá-Correia I
    Front Cell Infect Microbiol; 2019; 9():273. PubMed ID: 31417878
    [No Abstract]   [Full Text] [Related]  

  • 25. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
    St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD
    Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis.
    Porter LA; Goldberg JB
    Front Cell Infect Microbiol; 2011; 1():9. PubMed ID: 22919575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful Lung Re-transplant in a Patient with Cepacia Syndrome due to Burkholderia ambifaria.
    Goodlet KJ; Nailor MD; Omar A; Huang JL; LiPuma JJ; Walia R; Tokman S
    J Cyst Fibros; 2019 Jan; 18(1):e1-e4. PubMed ID: 30224331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on the Burkholderia cepacia complex.
    Lipuma JJ
    Curr Opin Pulm Med; 2005 Nov; 11(6):528-33. PubMed ID: 16217180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.
    Ramsay KA; Butler CA; Paynter S; Ware RS; Kidd TJ; Wainwright CE; Bell SC
    J Clin Microbiol; 2013 Dec; 51(12):3975-80. PubMed ID: 24048536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides.
    De Soyza A; Silipo A; Lanzetta R; Govan JR; Molinaro A
    Innate Immun; 2008 Jun; 14(3):127-44. PubMed ID: 18562572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan.
    Chang TH; Chuang YC; Wang JT; Sheng WH
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1301-1309. PubMed ID: 34674957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major Aspects of Burkholderia gladioli and Burkholderia cepacia Infections in Children.
    Bedir Demirdag T; Ozkaya Parlakay A; Aygar IS; Gulhan B; Kanik Yuksek S
    Pediatr Infect Dis J; 2020 May; 39(5):374-378. PubMed ID: 32118858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multifarious, multireplicon Burkholderia cepacia complex.
    Mahenthiralingam E; Urban TA; Goldberg JB
    Nat Rev Microbiol; 2005 Feb; 3(2):144-56. PubMed ID: 15643431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taxonomy and pathogenesis of the Burkholderia cepacia complex.
    Mahenthiralingam E; Vandamme P
    Chron Respir Dis; 2005; 2(4):209-17. PubMed ID: 16541604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linocin and OmpW Are Involved in Attachment of the Cystic Fibrosis-Associated Pathogen Burkholderia cepacia Complex to Lung Epithelial Cells and Protect Mice against Infection.
    McClean S; Healy ME; Collins C; Carberry S; O'Shaughnessy L; Dennehy R; Adams Á; Kennelly H; Corbett JM; Carty F; Cahill LA; Callaghan M; English K; Mahon BP; Doyle S; Shinoy M
    Infect Immun; 2016 May; 84(5):1424-1437. PubMed ID: 26902727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Method of Serum Resistance by Escherichia coli That Causes Urosepsis.
    Coggon CF; Jiang A; Goh KGK; Henderson IR; Schembri MA; Wells TJ
    mBio; 2018 Jun; 9(3):. PubMed ID: 29946047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular survival and innate immune evasion of Burkholderia cepacia: Improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors.
    Ganesh PS; Vishnupriya S; Vadivelu J; Mariappan V; Vellasamy KM; Shankar EM
    Microbiol Immunol; 2020 Feb; 64(2):87-98. PubMed ID: 31769530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa.
    Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR
    FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.
    Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E
    Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.